Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Emma Söreskog"'
Publikováno v:
SAGE Open Medicine, Vol 12 (2024)
Background and purpose: Losing independence is a main concern for hip fracture patients, and particularly not being able to return home. Given the large impact on quality of life by loss of independence and the high risk for institutionalization afte
Externí odkaz:
https://doaj.org/article/04acb6471eda4800a08038f9c75cebdf
Autor:
Terje Kirketeig, Emma Söreskog, Trolle Jacobson, Rolf Karlsten, Niklas Zethraeus, Fredrik Borgström
Publikováno v:
PAIN Reports, Vol 8, Iss 6, p e1107 (2023)
Abstract. Introduction:. Despite advancements in implanted hardware and development of novel stimulation paradigms in Spinal Cord Stimulation (SCS), real world evidence suggests a large variation in patient reported outcomes and a proportion of patie
Externí odkaz:
https://doaj.org/article/aac7e88782cf462f8df3a1864c391c2d
Autor:
null Thomas Nyström, null Emilie Toresson Grip, null Joel Gunnarsson, null Paula Casajust, null Kristina Karlsdotter, null Josefin Skogsberg, null Anastasia Ustyugova, null Moe H. Kyaw, null Maria Lajer, null Gitte Mateusen, null Lisette Koeneman, null Neus Valveny, null Emma Söreskog, null Riho Klement, null Fabian Hoti, null EMPRISE Study Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c902b3b3bbd218b6f51e1bd1d012824
https://doi.org/10.1111/dom.14870/v2/response1
https://doi.org/10.1111/dom.14870/v2/response1
Autor:
Emma, Söreskog, Trolle, Jacobson, Terje, Kirketeig, Peter, Fritzell, Rolf, Karlsten, Niklas, Zethraeus, Fredrik, Borgström
Publikováno v:
Pain.
Current research indicates that spinal cord stimulation (SCS) has a positive short-term impact on outcomes, such as quality of life, pain, and productivity in patients with chronic neuropathic pain. However, there is a need for studies on larger popu
Autor:
Anna Spångeus, Cesar Libanati, Jen Timoshanko, Emma Söreskog, G. Ortsater, Alireza Moayyeri, Jonas Banefelt, Kristina Åkesson
Bone mineral density (BMD) is an established measure used to diagnose patients with osteoporosis. In clinical trials, change in BMD has been shown to provide a reliable estimate of fracture risk reduction, and achieved BMD T-score has been shown to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271d2113d464b5e2341df139f31534a4
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180908
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180908
Autor:
Guillermo Villa, Emma Söreskog, S. Hallberg, Maria Svensson, Emil Hagström, Francesc Sorio Vilela
Publikováno v:
Advances in Therapy
Introduction The impact of additional risk factors on major cardiovascular event (MACE) rates in patients with a history of myocardial infarction (MI) or ischaemic stroke (IS) treated with statins is not well defined. Methods In this retrospective po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490b4601197e5e1c08b5d01e1b77507d
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-463951
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-463951
Autor:
Oskar Ström, Kristina Åkesson, Emma Söreskog, Mattias Lorentzon, F. Borgström, I. Lindberg, P. Berling, John A. Kanis, D. Willems
Publikováno v:
Osteoporosis International
Summary Romosozumab is a novel bone-building drug that reduces fracture risk. This health economic analysis indicates that sequential romosozumab-to-alendronate can be a cost-effective treatment option for postmenopausal women with severe osteoporosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57743aa862d4d2365e13450118e06a9
https://acuresearchbank.acu.edu.au/item/8w4qv/cost-effectiveness-of-romosozumab-for-the-treatment-of-postmenopausal-women-with-severe-osteoporosis-at-high-risk-of-fracture-in-sweden
https://acuresearchbank.acu.edu.au/item/8w4qv/cost-effectiveness-of-romosozumab-for-the-treatment-of-postmenopausal-women-with-severe-osteoporosis-at-high-risk-of-fracture-in-sweden
Autor:
Cesar Libanati, Anna Spångeus, E Toth, Mata Charokopou, Emma Söreskog, Fredrik Borgström, Jonas Banefelt, Oskar Ström, Kristina Åkesson
Background: Osteoporosis affects approximately one in five European women and leads to fragility fractures, which result in poor health, social and economic consequences. Fragility fractures are a strong risk factor for subsequent major osteoporotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb711fcf33cef54fd9d9f0be19167bd5
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-165644
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-165644
Autor:
Vistisen, Dorte1,2 (AUTHOR), Carstensen, Bendix1 (AUTHOR), Elisabetta, Patorno3 (AUTHOR), Lanzinger, Stefanie4,5 (AUTHOR), Tan, Elise Chia-Hui6 (AUTHOR), Yabe, Daisuke7,8,9,10 (AUTHOR), Kim, Dae Jung11 (AUTHOR), Sheu, Wayne H.-H.12 (AUTHOR), Melzer-Cohen, Cheli13 (AUTHOR), Holl, Reinhard W.4 (AUTHOR), Núñez, Júlio14 (AUTHOR), Ha, Kyoung Hwa11 (AUTHOR), Halvorsen, Sigrun15 (AUTHOR), Langslet, Gisle16 (AUTHOR), Karasik, Avraham13 (AUTHOR), Nyström, Thomas17 (AUTHOR), Niskanen, Leo18,19 (AUTHOR), Guleria, Sonia20 (AUTHOR), Klement, Riho21 (AUTHOR), Carrasco, Marc22 (AUTHOR)
Publikováno v:
Cardiovascular Diabetology. 8/31/2023, Vol. 22 Issue 1, p1-12. 12p.
Publikováno v:
SAGE Open Medicine; 6/13/2024, p1-9, 9p